Danny Grannick is the CEO and co-founder of Bristle Health, a company redefining oral health and care through the oral microbiome.
Oral diseases – like cavities and gum disease &#8211; are the most prevalent conditions on the planet, even though they are largely preventable. These diseases are attributed to imbalances in the oral microbiome. However, current standards for detecting and treating oral disease do not account for the oral microbiome – instead, they rely on reactive and ineffective tools like X-rays, observational screenings, and brute-force antibiotics.
Bristle is on a mission to help people improve their oral health – a critical but overlooked component of overall health connected to conditions including diabetes, cardiovascular disease, and Alzheimer’s. In 2021, they launched The Oral Health Test, the world’s first and only at-home oral microbiome test to provide detailed information about the microbes (fungi and bacteria) in your mouth associated with a variety of oral health conditions. Based on your results, Bristle develops a tailored 3-month treatment program – including personalized diet, oral care product, and hygiene recommendations &#8211; to rebalance the oral microbiome.
Danny earned his BA in biochemistry at the University of San Diego before moving into a commercial career in genomics. During his time, he worked with companies and researchers leveraging sequencing technologies in areas like oncology, NIPT, and the gut microbiome. Danny started Bristle after realizing that the same technology could be applied in the dental space to shift today’s reactive standard of care towards something personalized and preventive.